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Abstract and Key Terms 
Following injury to the central nervous system, extracellular modulations are apparent at 
the site of injury, often resulting in a glial scar. Astrocytes are mechanosensitive cells, which can 
create a neuroinhibitory extracellular environment in response to injury. The aim for this 
research was to gain a fundamental understanding of the affects a diffuse traumatic brain injury 
has on the astrocyte extracellular environment after injury. To accomplish this, a bioreactor 
culturing astrocytes in 3D constructs delivered 150G decelerations with 20% biaxial strain to 
mimic a traumatic brain injury. Experiments were designed to compare the potential effects of 
media type, number of impacts, and impacts with or without strain. Multiple impacts on 
astrocytes resulted in increased apoptosis, supporting cumulative effects of multiple traumatic 
brain injury events. Surprisingly, the expression of glial fibrillary acidic protein and S100B by 
astrocytes was downregulated following injury. With multiple impacts, astrocytes downregulated 
collagen and glycosaminoglycan expression at acute time points. Suppression of matrix 
metalloproteinase-2 coupled with unchanging production of transforming growth factor beta-1 
and tissue inhibitor of metalloproteinase-1 indicates an inability to degrade damaged ECM or 
produce new ECM. This was supported by long-term studies which indicate significant decreases 
in chondroitin sulfate proteoglycan and collagen I accumulation. This could suggest astrocytes 
experiencing damaging mechanical stimulation enter a survival state ceasing to moderate the 
extracellular environment at short time points after injury. 
 
Key terms: traumatic brain injury, astrocytes, extracellular matrix, glial scar, repeat injury 
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I. Introduction 
Traumatic Brain Injury 
Traumatic brain injury (TBI) is described as an alteration of brain pathology caused by an 
external force (1).  An estimated 1.7 million people in the U.S. experience a TBI annually, 
resulting in over 50,000 fatalities; however, the true number could be much larger as not all 
individuals that experience a TBI actively seek medical attention (2, 3). The incidence of TBI 
appears to have increased in recent years as TBI-related emergency department visits have 
increased 29% over a 5 year time span (4). The substantial proportion of the population affected 
by TBI creates an economic burden estimated to cost $63.4 billion to $79.1 billion from medical 
treatment and lost productivity (5).  
TBI can be classified by a variety of parameters given the nature of the injury (blast 
injury, closed head injury) and the severity of the injury (mild, moderate, severe) (6). The most 
common injury among these is mild traumatic brain injury (mTBI), often called a concussion, 
commonly associated with symptoms of headache, dizziness, and confusion acutely following 
injury (7). Symptoms can also include decreased cognitive performance (forgetfulness, difficulty 
in learning), altered sleep habits, and altered emotional behavior, though symptoms tend to 
resolve within 7-10 days (8, 9). Long-term, mTBI has been linked to depression in up to 48% of 
patients one year following injury (10). Additionally, chronic traumatic encephalopathy (CTE), a 
recently discovered diseased characterized by cognitive deficiencies, volatile emotional 
behavior, and motor disease, has been linked to repeated traumatic brain injury (11). One 
hypothesized cause bridging the gap from mTBI to CTE are the formation of neurofibrillary 
tangles caused by the release of pro-inflammatory cytokines subsequently activating astrocytes 
and microglia upon mechanical stimulation (12). CTE is most commonly known from extensive 
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media coverage for affecting professional athletes that maintained a career in contact sports, 
specifically football; however, the military population suffering repeated blast injuries is an 
underreported yet significant demographic affected by traumatic brain injury (13).  
Within the civilian population, young adults aged 15 to 24 years and the elderly over the 
age of 65 are at the greatest risk of suffering a TBI with the elderly having the highest mortality 
rates due to TBI (3). The most common cause of TBI occurs from falls, automobile accidents, or 
having the head strike or be struck by another object.  Deployed military personnel  are also at 
greater risks of suffering a TBI, specifically from blast injury, and are at greater risks of poor 
psychiatric health often suffering from post-traumatic stress disorder (14).  The heterogeneity of 
TBI complicates creating an all-encompassing model for injury. It is necessary for models of 
TBI to simplify the insult itself to create a platform for replicable injury which can be used to 
study the cellular response to TBI (15). To this end, a fundamental study was performed to 
evaluate the responses of central nervous system cells to rapid decelerations coupled with biaxial 
stretching.  
Modeling Traumatic Brain Injury 
Expanding our knowledge on the manner physical stimulation is translated into a 
biological response will be of vital importance to understand, predict, and treat TBI. Attacking 
this issue can be quite difficult; one must understand the mechanical properties of brain tissue, 
the nature of the mechanical forces during TBI, and the mechanisms within the cell that sense 
and respond to these forces.   
The tissue response of the brain to mechanical forces has been observed by performing 
mechanical testing on cortical tissue. The brain can be described as a viscoelastic material 
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possessing non-linear stress-strain behavior, hysteresis, and changing mechanical properties 
depending on strain rate (16).  Understanding the mechanical properties of brain tissue can help 
produce accurate finite element models that can be used to predict pressures, stresses, and strain 
within the brain during TBI (17, 18).  The nature of the mechanical stimulation can vary greatly 
as no single factor can predict the severity of injury (19). Factors can include rapid linear 
accelerations, rotational accelerations, the direction of impact, and impact duration (20). Linear 
accelerations have been shown to produce pressures, compression, and stretching which are one 
potential pathway to altered biological function. Likewise, rotational accelerations can produce 
shearing and stretching of cells inducing an injury response.  A threshold level of an 18% stretch 
on neurons has been suggested to invoke traumatic axonal injury, though this was performed in 
an animal model and may not translate to the human injury tolerance level (21). The findings 
from studies investigating biomechanics of head injury creates parameters for in vitro and in vivo 
models to replicate.  
Methods for modeling TBI in vitro and in vivo have been extensively reviewed (6, 22). 
Observing biological phenomena in vitro rarely translate directly to human physiology, therefore 
multitudes of animal models have been designed to study TBI in a complex system acting as an 
intermediate step. In vivo models for TBI reconstruct the mechanical stimulation of a traumatic 
brain injury. The most common TBI model used in animal studies is the fluid percussion injury. 
Briefly, this model produces TBI by way of a fluid pressure wave triggered by a weighted 
pendulum striking a lateral fluid column propagating the pressure wave onto an exposed surface 
of the brain resulting in cognitive and motor defects as well as biomarkers of injury (23). First 
reported by Dixon et al., controlled cortical impact is another popular model for TBI utilizing a 
piston to strike exposed brain tissue at high rates creating a focal injury that is highly 
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reproducible (24, 25). Weight drop models require a substantial mass confined in a guide tube to 
be released from a height and strike the animal’s head directly or on a plate covering the head 
causing diffuse injury (26, 27). Blast injury models inspired from soldiers exposed to explosions 
from the Iraqi and Afghan wars typically require placement of an animal into a metal tube that 
carries a pressure wave triggered by air or an explosion down the tube to the exposed animal 
(28).  Finally, models using angular acceleration as the only means of mechanical stimulation by 
sudden twisting of the animal’s head have been reported to cause diffuse brain injury (29). 
However, in vivo models suffer in isolating and observing specific biological phenomenon, 
controlling and measuring cellular and tissue mechanics, experiencing greater variability animal-
to-animal, and requiring substantial increases in monetary cost for experiments.  
 In vitro TBI models are advantageous because of the ability to investigate specific 
pathobiological phenomena by tightly controlling experimental variables and mechanical 
stimulation. Commonly, in vitro models will utilize primary cultures, mixed cultures, or 
organotypic slice cultures (30). Primary cultures allow one to investigate specific pathways and 
mechanisms for one cell type while mixed cultures can provide insights into the interplay 
between different cells in mounting a response to injury. One common injury model requires the 
stretching of cell cultures or organotypic slice cultures on an elastic membrane (31). La Placa 
and Thibault developed a model invoking shear stress on neuronal cultures (32). Compression 
models have also been developed by dropping weights onto cell cultures (33). The wide plethora 
of in vitro TBI models examines specific mechanisms of injury providing specific insights into 
an injury response. To this end, we sought to develop an in vitro TBI bioreactor capable of 
applying multiple types of mechanical stimulation to primary cultures to increase the knowledge 
of the behavior of cells after suffering a traumatic brain injury. 
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The Role of Astrocytes in the Central Nervous System 
The central nervous system (CNS) remains one of the most complex and least understood 
organ systems in the body. The CNS is comprised of the brain and spinal cord and acts as the 
integration center for receiving sensory information and transmitting a response to the rest of the 
body.  Within the parenchyma of the brain and spinal cord, cells can be classified as either 
neuronal, endothelial, or glial cells. Neurons function by converting chemical, mechanical, or 
temperature stimuli into an electrical signal. The electrical signal known as an action potential is 
relayed to other neurons ultimately invoking a cognitive and motor response. Neurons are the 
functional cell type within the CNS responsible for our ability to sense our surroundings, form 
consciousness and thought, develop emotions, and generate signals for the body’s organs to 
function. Endothelial cells create the vascularization within the brain playing a pivotal role of 
supplying CNS cells with nutrients and gas transport from the blood while blocking the passage 
of large molecules and pathogens. In approximately equal number to neurons is the “glue” of the 
brain in glial cells acting to support neuronal health, guide neurons in development,  and regulate 
synapse formation (34). Glial cells include microglia, oligodendrocytes, and astrocytes. 
Microglia act as immune responders to pathogens entering the CNS as well as phagocytes to 
remove apoptotic cells. Oligodendrocytes are primarily found within the white matter of the CNS 
and are responsible for producing myelin sheath. Myelin created by oligodendrocytes act as an 
insulating barrier encircling axons to increase the speed of the action potential. Astrocytes carry 
out many essential functions including the production of extracellular matrix within CNS tissue 
and is the focus of this research henceforth. 
Astrocytes are specialized glial cells responsible for maintaining homeostasis for neurons 
critical to survival (35). Astrocytes can be subdivided into two groups; protoplasmic astrocytes 
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are located in gray matter rich in neuronal cell bodies while fibrous astrocytes are found in the 
white matter where myelinated axons and oligodendrocytes are localized interacting with the 
nodes of Ranvier (36). However, the broad grouping of astrocytes into two groups may not be 
accurate as growing evidence supports heterogeneity of astrocytes in different regions of the 
brain. Astrocytes also bridge the gap between neurons and blood vessels modulating blood flow 
to specific regions of the brain by signaling endothelial cells to constrict or dilate controlling 
blood flow based on synaptic activity of the neighboring neurons (37). Astrocytes are also 
believed to aid in formation of the blood-brain barrier with end-feet coming into direct contact 
with endothelial cells (38).  
At the synapse of neurons, astrocytes facilitate the recycling of neurotransmitters by 
uptaking released neurotransmitters and converting the molecules back to precursors that are 
then delivered to the axon terminal to be reused by the neuron (39). Though astrocytes do not 
‘fire’ propagating an action potential like neurons, growing evidence indicates astrocytes 
participate in passing and modulating signals at the synapse. Known as the ‘tripartite synapse’, 
astrocytes possess G protein-coupled receptors that can be activated by neurotransmitters 
released from the presynaptic neuron like glutamate causing a rise in calcium levels within the 
astrocyte (40, 41). Evidence has shown in response to increased intracellular calcium astrocytes 
may release gliotransmitters such as glutamate, GABA, and ATP into the synapse (42). Studying 
the tripartite synapse is still in its infancy as many questions remain on the mechanisms involved 
in the release of gliotransmitters and if neurons truly respond to gliotransmitters.  
Astrocytes are believed to tightly regulate interstitial fluid volume in the brain through 
the aquaporin-4 water channel (43). For energy, astrocytes act as the mediator of the uptake of 
glucose from the blood stream to neurons. Astrocytes also act to store glycogen that can be 
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metabolized and delivered to neurons as lactate during periods of hypoglycemia or localized high 
activity (44).  
Additionally, astrocytes generate the ECM in the CNS. As in other tissues, the ECM acts 
to create structure and provide chemical cues to cells.  In development, astrocytes can guide 
axons by secreting chondroitin sulfate proteoglycans (CSPGs) and tenascin-C that prevents 
axons from growing across these extracellular matrix proteins (45). The ECM of the CNS is 
unique in that it lacks the fibrous collagen backbone observed in other tissue’s ECM and instead 
creates a mesh of glycoproteins and proteoglycans chiefly relying on hyaluronic acid. 
Surrounding blood vessels, astrocytes deposit a basement membrane comprising of laminin, 
fibronectin, heparin sulfate proteoglycans (HSPG), and collagen IV functioning to maintain the 
blood-brain barrier (46). Within the parenchyma, the most prominent ECM feature are 
perineuronal nets localized at synapses. Perineuronal nets are comprised of dense meshwork of 
CSPGs, tenascins, and hyaluronic acid and are believed to function to provide structure to the 
synapse and allow synaptic plasticity (47). Likewise, the neural interstitial matrix is built by the 
same proteoglycans as the perineuronal nets, though are located away from synapses. When 
exposed to insult or injury, astrocytes have the capacity to remodel the extracellular environment 
to minimize damage to surrounding tissue. It is less understood how astrocytes recognize injury 
and what ultimately triggers the remodeling of the ECM following injury.    
The Injury Response in the Central Nervous System 
Astrocytes are known to respond to any CNS insult like traumatic brain injury, formally 
known as reactive gliosis. In vivo and in vitro studies alike have demonstrated astrocytes 
proliferating at the site of injury, increase expression of intermediate filaments glial fibrillary 
acidic protein (GFAP) and vimentin, and increase expression of chondroitin sulfate 
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proteoglycans, laminin, and collagen IV (48-50). With TBI, one potential side effect is increased 
cranial pressure caused by edema in the brain. As mentioned previously, astrocytes tightly 
regulate the volume of interstitial fluid within the brain. Upon injury, research suggest astrocytes 
swell within hours causing an increase intracranial pressure with increased pressure correlating 
to poorer patient outcomes (51). Swelling has been suggested to be incited by increased 
expression of aquaporin-4 water channel as well as the activation of nuclear factor-κB (NF-κB) 
(52, 53). 
Another known response to traumatic brain injury is the breakdown of the blood-brain 
barrier (BBB). Increased permeability of the BBB is an additional source of fluid build-up and 
greater intracranial pressure (51). Increased permeability of the BBB allows immunoglobulin G 
and albumin pass the BBB causing an inflammatory response in the parenchyma of the CNS 
(54). The initiation of an inflammatory response can create a signaling cascade causing the 
release of cytokines such as tumor necrosis factor-α and interlukin-1β that are toxic to neurons 
and cause reactive gliosis (54). Ultimately, the activation of astrocytes can lead to significant 
extracellular changes after injury. 
Of particular interest to our group is understanding the extracellular changes driven by 
astrocytes which reshape the ECM after sustaining injury. In focal injuries (i.e. penetrating 
injuries, gunshot wounds), an evident scar region can form comprised of GFAP-positive 
astrocytes producing (CSPGs) in an effort to isolate the injury, thereby limiting the spread of 
inflammation and tissue damage. In the short term, this is advantageous for limiting damage to 
neighboring healthy tissue; however, the scarred region inhibits long-term neuron growth, thus 
preventing the reformation of any neural connections lost during injury. Astrocytes further 
modify the extracellular environment with increased expression of fibronectin and laminin 
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believed to aid in macrophages clearing dying cells and repair the BBB, respectively (55). 
However, in diffuse traumatic brain injury, an injury site and glial scar formation may not be 
apparent. A greater understanding of changes in the extracellular environment driven by 
astrocytes could provide needed insights into the diagnosis and treatment of TBI. Further, it is 
our goal to determine the mechanical mechanisms in which astrocytes sense injury and how 
astrocytes may affect the extracellular environment. 
Thesis Statement 
Previously, we have reported a novel bioreactor capable of delivering mechanical 
stimulation mimicking a traumatic brain injury (56). The bioreactor is unique in that it 
implements inertial loads onto cells while simultaneously applying biaxial strain. We 
hypothesize mechanical stimulation causes fundamental changes in the composition and 
production of extracellular matrix proteins by astrocytes at acute time points after a TBI event. 
The aims for this project were to first validate the bioreactor mimicked mechanical stimulation 
experienced by the brain that results in a traumatic brain injury. Validation of the injury model 
was accomplished by observing astrocyte survival and behavior for key markers of reactivity. 
Extracellular matrix alterations were observed in astrocyte cultures through monitoring gene 
expression, cytokine secretion, and immunofluorescence labeling of structural and adhesion 
proteins. The outcome for this study was to observe and present astrocyte behavior and 
alterations to the extracellular environment after simultaneous exposure to inertial loads and 
stretch analogous to a TBI, while investigating potential cumulative effects with multiple 
injuries, and observe changes to the astroglial response to injury when cultured with or without 
serum.  
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II. Material and Methods 
TBI Bioreactor Fabrication 
The TBI bioreactor used is that which was previously reported by Heller et al. and can be 
used for an in depth characterization of the bioreactor (56). The TBI bioreactor contains four 
components; a guide rod, drop shuttle, polypropylene cell culture drum and a spring-damped 
base. The guide rod is comprised of a steel rod (diameter = 3cm, length 2m) press-fit into an 
aluminum base plate (Fig 1A). The guide rod acts to constrict the motion of the drop shuttle to 
one vertical direction. The shuttle is made from two aluminum plates encompassing an 
intermediate polypropylene plate (Fig 1B). The top aluminum plate has a linear bearing attached 
to allow nearly frictionless motion along the guide rod. Six small circular holes were cut from 
the polypropylene layer that act to house the cell culture drums during impacts. The bottom 
aluminum plate contains six circular holes coincident to the openings in the polypropylene layer 
that allow custom indenters to apply biaxial strain to the culture upon impact (Fig 1C). 
Increasing the height of the indenter coincides with increased strain on the cell culture. Indenter 
heights of 5mm caused 20% biaxial strain on the cell culture. Cell culture drums utilize a porous 
polyurethane foam created using a technique familiar to our lab (Fig 2). Wetted sugar was 
packed into silicone molds and dried in an oven at 70ºC for 30 minutes. Polyurethane dissolved 
in dimethylacetamide (DMAC) (10% weight by volume) was pipetted drop by drop onto the 
sugar mold. Polyurethane was cured and sugar dissolved by placing molds in repeated deionized 
water baths over three days. Medical grade polydimethylsiloxane (PDMS) placed beneath the 
scaffold is secured by a silicone O-ring and creates a watertight seal. The impact base is 
comprised of a square steel plate mounted onto an interchangeable spring (Fig 2). 
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Characterization of TBI Bioreactor 
A uniaxial ±300G accelerometer was mounted onto the drop shuttle and connected to a 
16-bit data acquisition card (National Instruments). Samples were collected at 10,000 Hz. A 
custom-built LabVIEW program converted accelerometer voltage output (-2.5V to 2.5V) to 
gravitation. The bioreactor was characterized with three different spring bases for impact 
duration (n=25) and peak deceleration. A linear relationship for the peak deceleration for each 
spring was established by releasing the drop shuttle at 25cm increments up to 175cm above the 
spring-damped base (n=5, per height). Biaxial strain was validated optically using a digital 
camera and three microspheres as markers. Pre-stretch and post-stretch images were acquired. 
Monitoring the change in distance between each microsphere after deformation generated values 
for circumferential, radial, and shear strain. 
Isolation of primary rat astrocytes 
Primary cortical rat astrocytes were isolated from 1-day old neonatal rat pups following a 
modified procedure previously reported (57). Rat astrocyte cortexes were separated from all 
meninges and blood vessels and digested in dissociation media (0.2% collagenase/DNase) for 
two hours. Dissociated cells were treated with 0.25% Trypsin (Gibson), then passed through a 
cell strainer. Finally, cells were rinsed and centrifuged in 1X PBS supplemented with glucose. 
Mixed glial and neural cells were seeded onto laminin-coated cell culture flasks. Mixed glial 
cultures were grown in DMEM F-12 media (Gibco) supplemented with 10% Fetal bovine serum 
(FBS), 1% Penicillin/Streptomycin, and 1% l-Glutamine and allowed to reach confluency (7-9 
days) with media exchanges occurring every two days. Mixed glial cultures were then subject to 
orbital shaking for twenty-four hours at 200 RPM to detach loosely adherent neurons, microglia, 
and oligodendrocytes. Purified astrocytes were passaged to culture flasks until the desired cell 
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number was achieved. Astrocyte purification was validated by immunostaining for the presence 
of glial fibrillary acidic protein (GFAP), a common marker for astrocytes (Appendix A) (58, 59). 
A threshold of 90% GFAP positive cells was used in determining if cultures were astroglial 
enriched cultures or mixed glial cultures (60). Cultures were maintained in an incubator at 37°C, 
95% humidity, and 5% CO2. 
Experimental Design 
Astrocyte cultures were divided into multiple subsets to explore potential differences in 
cellular response given different culturing parameters. The first parameter explored was the 
effect of serum-containing media (10% fetal bovine serum) against serum-free media (N-2 
Supplement) (61, 62). The difference in media aimed to mimic an open head injury with the 
presence of blood at the injury site against a closed head injury where blood may not be present 
throughout the injury. The second parameter compared the reaction of cells to a single TBI 
mimetic impact against those receiving a second TBI mimetic impact twenty-four hours after the 
first impact. Previous work has shown graded cognitive differences and astroglial reactivity 
indicative of a cumulative response to TBI as well as heightened sensitivity to injury shortly after 
an initial impact (26, 63, 64). The third parameter evaluated the response of astrocyte cultures to 
receiving a 150G impact with 20% biaxial strain against cultures receiving a 150G impact 
without strain. To this end, we sought to compare the nature of the stimulus that brought about 
reactivity and changes in astrocyte behavior post injury. A total of 8 experimental groups were 
tested represented by all combinations of the parameters listed previously (n=4 minimum per 
group).  
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Mimetic TBI Impacts 
Prior to seeding, cell culture drums were incubated in laminin (10ug mL-1, Gibco) 
overnight to promote cell adhesion. Astrocytes were seeded onto the center (10mm diameter) of 
the fabricated TBI bioreactor drums at a concentration of 4.5×105 cells per drum. Cells were 
given seventy-two hours to adhere and proliferate within the drum. Forty-eight hours prior to the 
first impact, cultures designated as serum-free were switched to serum-free media. Neurobasal 
serum-free media comprised of DMEM/F-12 media with 1% N-2 Supplement (Gibco), 1% 
Pen/Strep, and 1% l-Glutamine. Releasing the drop shuttle 170cm above the base corresponded 
to a 150G impact. The use of 5mm indenters onto the base of each cell culture provided 20% 
biaxial strain. Medium was removed from each cell culture immediately before impact and fresh 
medium added immediately following impact. The time out of media was recorded for each 
culture, spending a total of 5-7 minutes out of media. A second impact was given twenty-four 
hours after the initial impact to cultures designated for that parameter. 
Cell Viability Assay 
Relative cell viability was established using a modified MTT cell proliferation procedure 
(Life Technologies). Cultures received mimetic TBI impacts as described above. Forty-eight 
hours following impact, cultures were rinsed with DMEM/F-12 media without phenol red and 
incubated in 1mL MTT solution (1.2mM) for two hours. 75% of the solution was aspirated 
following incubation and replaced with dimethyl sulfoxide (DMSO). The resulting precipitate 
was solubilized by agitation through repeated pipetting. Solution was transferred to a 96 well 
plate and absorbance at 540nm was measured (BioTek Synergy Mx). A standard curve was 
generated using known cell culture concentrations and experimental results were referenced to 
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the standard. Reported cell viability is expressed relative to the single impact, serum-containing 
control.  
Reverse transcription-PCR (RT-PCR) analysis 
Two separate RT-PCR experiments were performed targeting reactive gliosis and 
extracellular matrix substrates. Exploring reactive gliosis, extraction of cells from culture for all 
experimental groups (n=4-5/group) occurred twenty-four hours following the terminal impact 
while for extracellular matrix production extraction occurred six hours following the final impact 
for all experimental groups (n=4/group).  Cell culture foams were removed from the cell culture 
drum using a scalpel and stored in RNAProtect (Qiagen) at -80°C. RNA was isolated using 
RNeasy Mini Kit Plus (Qiagen) following manufacturer’s protocol. Genomic DNA was 
eliminated by passing RNA through gDNA Eliminator Spin Column (Qiagen) during the RNA 
isolation procedure. RNA samples were reverse transcribed using iScript cDNA Synthesis kit 
(Bio-Rad) following the manufacturer’s protocol. cDNA samples were appropriately diluted for 
RT-PCR analysis so that all samples contained the same concentrations of cDNA. In studying 
reactive gliosis, GFAP, S100B, and Vimentin primers were commercially purchased (Bio-Rad). 
For extracellular matrix production, primers for Collagen I, Versican, and Neurocan were also 
commercially obtained (Bio-Rad). SsoAdvanced Universal Sybr Green Supermix (Bio-Rad) 
acted as the fluorescent label to monitor amplification of the target genes. ECM protein 
expression was normalized to GAPDH expression relative to the control sample using the ∆∆Ct 
method. Cycling conditions were 40 cycles at 95°C for 5 seconds and 60° for 30 seconds 
following manufacturer’s recommendations (Bio-Rad CFX96 Touch). 
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Extracellular and Inflammatory cytokine analysis 
Cell culture supernatants were collected forty-eight hours following the final impact. 
Cytokine concentrations from cell culture supernatants were measured using colorimetric 
sandwich ELISAs (R&D Systems) for Matrix Metalloproteinase 2 (MMP-2), Tissue Inhibitor of 
Metalloproteinases 1 (TIMP-1), and Transforming Growth Factor Beta 1 (TGFβ-1) following the 
manufacturer’s protocol. Cytokine concentrations are presented relative to viable cells found 
from the MTT assay and reported as production of cytokine per cell (fg cell-1) 
Measurement of Matrix Accumulation 
To investigate the effect of repeated impact on cellular matrix accumulation, astrocyte-
seeded porous polyurethane foam culture inserts were impacted (150g combined with 20% 
strain) every 2-3 days for a total of three weeks (9 impacts total). The repeated impact regime 
was designed to imitate an in-season football training schedule, during which athletes have been 
shown to experience up to 900 head impacts. Serum-containing media (10% FBS) was 
exchanged every 2-3 days throughout the conditioning period. Following the three-week 
conditioning period, impacted and static control samples were fixed in 4% paraformaldehyde, 
permeabilized with 0.05% triton and stained for the presence of collagen type I (Sigma 1:500) 
laminin, (Sigma 1:1000) and chondroitin sulfate proteoglycan (CSPG, Sigma 1:500) followed by 
the appropriate fluorescently labeled secondary detection antibodies (Life Technologies, 
Alexafluor, 1:500). The intensity of fluorescence against collagen, laminin, and CSPG for each 
sample was used to estimate matrix accumulation. Immunoreactivity was quantified using 
relative fluorescence intensity for each scaffold measured with the aid of a plate reader (Synergy 
HT, Bio-Tek Instrument Inc., VT) using techniques familiar to our group. Cells were 
counterstained with the nuclear labeling reagent DAPI. Fluorescence values were normalized to 
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cell count for each sample. Cell counts were estimated from DAPI images. Microscopic images 
were also obtained for qualitative analysis and comparison. 
Statistics 
Results are presented as mean ± SEM. A two-way ANOVA with post hoc Tukey test 
determined statistical difference for experimental groups in cell viability assay, cytokine assay, 
and immunostaining. Student’s T-test was used to determine statistical differences for gene 
expression and characterizing the device. P values less than 0.05 indicate significantly different 
populations.  
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III. Results 
Device Characterization 
The first aim was to investigate the critical release height so that the entire shuttle was 
subject to linear decelerations and impact durations analogous to that felt during a TBI event. 
Impact duration followed an expected trend with the stiff spring (spring constant, 959lbs in-1) 
having the shortest impact duration and the flexible spring (90lbs in-1) experiencing the longest 
impacts (Table 1). The desired impact durations matching reported physiological conditions were 
met using the medium (312lbs in-1) or flexible spring giving impact durations of 9.2 ± 1.2ms and 
19.3 ± 0.5ms respectively compared to 1.6 ±  0.3ms for the stiff spring(65). Impact duration was 
not affected by the drop height of the shuttle for each spring. Each spring-damped base is 
significantly different from the others for impact duration.  For each spring, a linear relationship 
between peak deceleration and release height exists (Table 1). The flexible spring base reached a 
maximum deceleration of 59.1 ± 4.3G when dropped from the highest release point. Though 
some reports have described individuals with concussive symptoms after experiencing similar 
head decelerations, it does not encompass all individuals who may have a higher threshold to 
TBI events. In comparison to the flexible spring, the medium and stiff spring reached maximum 
decelerations of 158.2 ± 28.8G and 184.5 ± 26.6G when dropped from the highest release point. 
Measured impacts reaching these extreme decelerations are likely to cause symptoms associated 
with mild or severe TBI(66).  From these characterization trials, we chose to use the medium 
spring-damped base.  Using the established linear relationship, for all experiments 150G impacts 
were obtained by dropping the shuttle from 170cm above the medium spring-damped base.  
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Cell Viability  
A modified MTT assay was used to quantify cell survival for the experimental group 
relative to control groups (Fig 3). Cultures receiving serum and a single impact exhibited the 
strongest cell survival, retaining 79.4 ± 6.6% viable cells following a mimetic TBI compared to 
the single impact, serum-containing control. Withholding serum from media contributed to a 
trend of decreased cell survival as the control and single impacted cultures viable cell counts 
were 81.9 ± 11.4% and 81.9 ± 12.1% respectively relative to the serum control. Furthermore, a 
second impact significantly decreased viable cell counts to 59.0 ± 4.5% in impacted cultures 
supplemented with FBS and 45.4 ± 11.3% in serum-free cultures relative to the control. The 
combination of serum-free media and two impacts created a particularly hostile environment for 
astrocyte survival. Subsequent long-term studies were consistent with these findings as cultures 
withheld from serum were not capable of surviving multiple impacts over a 3-week span (data 
not shown). 
Gene Expression for Astrocyte Reactivity  
We hypothesized astrocytes would increase expression of intermediate filaments GFAP 
and vimentin as well as a reported inflammatory marker S100B based on previous in vivo and in 
vitro studies(67, 68). Surprisingly, we did not observe an increase in any of these proteins 24 
hours after mimetic TBI impacts (Fig 4). Across all conditions, impacted cultures decreased 
GFAP and S100B compared to all controls (p<0.0001). The number of impacts or media type did 
not have an effect on gene expression. Vimentin expression remained relatively unchanged 
compared to controls with the exception of astrocytes receiving serum-containing media and 
impacted once decreasing relative gene expression compared to control (p=0.0005). Although 
astrocytes withheld from serum receiving a single mimetic TBI upregulated vimentin three-fold, 
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this result was not significant from the control (p=0.071). GFAP expression was decreased 
across all experimental groups, though only significantly in one impact serum groups (p=0.0011) 
and astrocytes withheld from serum receiving two mimetic TBI’s (p=0.0238). S100B was 
consistently downregulated by all astrocytes receiving mimetic TBI with cultures receiving two 
impacts while withheld from serum displaying the greatest decrease from the control. 
Extracellular Matrix Gene Expression 
Quantitative reverse transcriptase PCR analysis for structural ECM proteins (Fig 5) 
revealed that astrocyte cultures receiving two mimetic TBIs exhibited decreased collagen I 
expression (p<0.0001, serum and serum-free). The absence of this observation in the single TBI 
condition could indicate a cumulative effect of TBI. Likewise, vesicant (p=0.0040) and neurocan 
expression (p=0.0039) decreased for astrocytes impacted twice receiving serum-containing 
media. Versican expression was also decreased in the single impact serum-containing media 
condition (p=0.0136), indicating a combination of impacts and presence of serum could suppress 
versican expression. Neurocan expression levels for all impacted groups decreased compared to 
controls, though only significantly as discussed previously. Overall, cultures receiving serum-
containing media and two impacts exhibited reduced expression for ECM proteins, indicating 
that astrocytes were producing extracellular matrix at a dampened rate compared to healthy 
astrocytes.  
Cytokine Secretion 
Secreted cytokines regulating ECM turnover and inflammatory cytokines promoting 
ECM production were normalized to the viable cells found previously and reported as the 
production of cytokine (fg) per astrocyte (Fig 6). Production of TGFB-1 was affected by the 
 20 
presence of serum and the number of impacts. Cultures receiving serum-containing media 
demonstrated an increased expression of TGFB-1 compared to serum-free cultures.  
Interestingly, astrocytes in serum-free media receiving a second impact increased TGFB 
production (5.9 ± 0.5 fg cell-1) compared to controls (2.8 ± 0.8 fg cell-1), an expected trend that 
was not evident in any other experimental group. A common trend was observed in astrocytes 
receiving mimetic TBI decreasing MMP-2 production no matter the media type or number of 
impacts. Excluding cultures in serum-free media receiving two impacts, all other impact 
conditions decreased MMP-2 by at least half compared to the controls. A significant difference 
was not observed in MMP-2 production across number of impacts, but was observed in media 
type. One of the inhibitors for MMP-2, TIMP-1, was not affected by injury, number of impacts, 
or media type. A miniscule trend of increased TIMP-1 production was observed for most injury 
conditions; however, it was not considered a significant increase. Interestingly, TIMP-1 
production dominates MMP-2 production in both control and injured astrocytes. TIMP-1 inhibits 
MMP-2 in a 1:1 stoichiometric ratio, therefore we quantified the overall inhibitory behavior of 
degrading ECM in astrocytes after impacts by investigating the ratio of TIMP-1 to MMP-2 
produced by astrocytes. Comparing across media types, cultures receiving serum supplemented 
media had a significantly increased TIMP-1/MMP-2 ratio. Within one or two impact groups 
there were no statistical differences.  In all cohorts, astrocytes impacted with strain experienced a 
significant increase in TIMP-1/MMP-2 ratio. This indicates that the combination of serum-
containing media (hemorrhaging) and mechanical stimulation from stretching and impacts can 
create an inhibitory environment for the degradation of ECM molecules. An important outcome 
of note is the inhibited release of important growth factors bound into the ECM. This could play 
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into the somewhat delayed activation of astrocytes after injury as some reports have shown 
astrocyte reactivity peaking 4-7 days following injury(69). 
Matrix Immunostaining 
  Using immunostaining, collagen, laminin and CSPG accumulation as well as astrocyte 
distribution were evaluated following three weeks of conditioning for both impacted and control 
porous polyurethane samples. At the end of the three-week conditioning period, astrocytes were 
well-distributed throughout the scaffold for both control and impacted cultures. Quantitative 
immuno-histochemical analysis demonstrated that the relative intensities of immunoreactivity to 
CSPG, laminin and collagen type I were decreased when compared to un-impacted controls (p < 
0.05) Qualitative observations confirmed the quantitative analysis (Fig. 7). 
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IV. Discussion 
We present a unique bioreactor subjecting cells to mechanical stimuli that would likely 
lead to traumatic brain injury in vivo. The bioreactor provides a model between pure in vitro and 
in vivo studies. This bioreactor, to our knowledge, is unique in its ability to simultaneously 
expose cells to rapid decelerations, like that in an impact resulting in TBI, while applying biaxial 
strain. Moreover, three-dimensional cultures are an important parameter to better mimic the 
structure of native tissue capturing cell pathology that may be lost when cultured in 2D (70). The 
created bioreactor is advantageous because of the flexibility in experimentation. In this study, we 
examined astrocytes cultured in three-dimensional foams; however, the foam can be 
interchanged allowing for the study of cells in monolayer, three-dimensional hydrogels or even 
organotypic cultures. The bioreactor also has the ability to house primary cells, co-cultures of 
astrocytes and neurons, or mixed glial cells. With the complex nature of the bioreactor, the 
mechanical stimulation given to individual cells is less understood. The pore structure of each 
foam used for cell culture is unique making it impractical to attempt to map stresses and strains 
across the entire foam. Additionally, the bioreactor cannot impose angular decelerations often 
associated with TBI, nor control strain rate. Both in vivo and in vitro studies alike have 
demonstrated a graded injury response to rotational accelerations and strain rates (71, 72). Our 
results support astrocyte cultures respond to the mechanical stimulation delivered by the 
bioreactor. 
Several in vitro models utilize a stretch injury, while neglecting inertial loading on the 
cells. Some may argue astrocytes in our bioreactor are incapable of sensing inertial forces 
because of the small mass of individual cells (~3x10-9 g) resulting in minute forces on the cell. 
Other cell types have exhibited sensitivity to inertial forces. Lung, cardiac, chondrocyte, and 
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osteoblasts can modulate ECM production triggered by changes in gravitational forces (73-76).  
Applying vibration to mouse vertebrate ex vivo and in vivo stimulated production of extracellular 
proteins (77).  An in vitro model inducing shear strain on organotypic cultures using inertial 
loading increased cell death after injury (78). Because of the sensitivity to Newtonian forces 
exhibited in other cell types, it is reasonable to assume astrocytes are capable of sensing and 
responding to the decelerations created by our bioreactor modulating the ECM. Under the 
experimental regime described above, astrocytes experiencing a 150G deceleration without 
biaxial strain altered expression and production of ECM proteins often exhibiting a medial 
expression between control and 150G impacts with strain (Supplemental Figure 1).  
A hallmark of injury to the central nervous system is reactive astrogliosis, resulting in the 
proliferation of astrocytes, increased expression of intermediate filaments after injury, and 
increased production of CSPGs (65, 66). We observed forty-eight hours following injury, the 
number of viable cells was decreased between 13-55% depending on the media type or impact 
number. These values are similar to a stretch injury TBI model performed in vitro (79). We also 
report astrocytes decreased GFAP expression after experiencing injury in our model. Zhao et al. 
observed decreased immunoreactivity to GFAP in hippocampal astrocytes at acute time points 
after TBI in a rat model as well as pronounced astroglial death (80). This could indicate the 
injury applied in our model is severe, leaving astrocytes in a damaged state. In comparison, 
though not explicitly stated, examination of human cerebellum after TBI displayed correlations 
between decreased GFAP expression and increased caspase 3 expression, indicative of cell 
apoptosis (81). The decreased expression of S100B can support the claim that astrocytes are 
severely damaged in our model as S100B has shown protective effects in neuronal-glial co-
cultures in vitro after stretch injury (68). Subsequently, high incidences of neuronal death have 
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been observed in the same brain regions of astroglial death, which may contribute to the 
symptoms associated with TBI (80). An interesting parallel is the decrease in GFAP expression 
in astrocytes by depressed and suicidal patients (82, 83). Long term depression and fatigue have 
been associated with TBI (84). Although we do not prove that inertial impacts induce these long 
term symptoms, it is an observation of note to see similar effects in our experiment.  
We observed differences in astrocyte behavior in response to a single injury, two injuries, 
and multiple injuries. With respect to ECM expression, a second injury caused significant 
decreases in collagen, versican, and neurocan expression in the serum-containing cohort. After 
implementing multiple injuries over a three-week time period, we observed decreased ECM 
accumulation in injured cultures. These observations suggest the number of impacts may have a 
role in how astrocytes modulate the ECM. Multiple impacts have proven translational from in 
vitro models to clinical studies. It is widely accepted that individuals with a previous history of 
TBI are more susceptible to a second injury, especially in the days following a TBI (85). In an in 
vitro stretch injury model, co-cultures of neuronal and glial cells exhibited increased uptake of 
propidium iodide after a second injury indicative of cell damage, thus demonstrating how CNS 
cells are sensitive to a second injury (86). Likewise, repeated fluid percussion injury subjecting 
Long-Evans hooded rats to single or multiple injuries demonstrated behavioral differences, 
memory impairment,  and increased inflammation short-term and long-term (87). To our 
knowledge, this is the first study to investigate the potential cumulative effect of repeated TBI on 
the composition and production of extracellular matrix.    
The extracellular matrix in the brain is unique in that it is constituted by glycoproteins 
(and proteoglycans as opposed to other ECM in tissues having a fibrillary base, typically 
collagen.  ECM in the brain functions to provide structure to CNS cells, guide axon growth in 
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development, form perineuronal nets, and create the blood brain barrier. We examined the 
potential fibrotic-like scar formation through the expression of collagen I. Although lacking 
fibrillar elements in the central nervous system, astrocytes have been reported to produce 
fibrillary collagen in vitro (88). Fibrotic scars have been reported in lesion injuries to CNS, 
though this is likely induced by invading meningeal fibroblasts (89).  In our study, we found a 
suppression in expression of collagen I in cultures receiving multiple injuries. It has been shown 
that TGFB-1 increases the production of collagen in astrocyte (89), thus the static nature of  
TGFB concentrations between control and TBI groups coupled with the downregulation of 
collagen indicates a strong inhibitory pathway is likely in play. Epidermal growth factor, tumor 
necrosis factor alpha, and interferon gamma all suppress the production of collagen in astrocytes 
in vitro(88). Surprisingly, we did not observe indications of the formation of a glial scar or 
increased matrix metalloproteinase activity. This observation is not without precedent, as 
versican, neurocan, aggrecan, and phosphacan have been reported to decrease expression near 
the injury site of a controlled cortical impact in a rat model (90). It appears clear that the injury 
invoked on astrocytes in this model do not initiate the formation of a glial scar. The decreased 
extracellular matrix protein expression coupled with suppressed production of MMP-2 indicates 
the injured astrocytes are incapable of turning over damaged ECM, while also unable to produce 
new ECM. In studies inhibiting MMP-1, synaptogenesis after injury was hampered with MMP-1 
inhibited, thus suggesting degenerating ECM after injury is crucial for proper recovery (91). The 
suppressed production of MMP-2 could correlate to decreased brain plasticity after TBI.  The 
negative affects of damaged ECM on cells has been demonstrated in mesenchymal stem cells 
when implanted into decellularized scaffolds isolated from cardiac tissue after infraction (92).  
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Serum-containing media simulates a disruption of the blood brain barrier after injury, 
often scene in moderate to severe cases of TBI. The serum-free condition with the high 
mechanical load presents a unique model in that astrocytes experience a severe TBI, yet are not 
exposed to the factors that would normally be released upon the disruption of the BBB found 
with severe TBI. While serum-containing conditions may be more physiologically relevant, 
withholding serum from cultures provides insights to the potential protective effects of the 
breakdown of blood vessels and subsequent release of blood upon injury. Serum-free conditions 
inherently reduce cell viability, as observed in both TBI and control serum-free conditions; 
however, impacting cultures resulted in a far greater reduction in viable cell counts. 
Comparatively, as little as 20% cell survival has been reported in astrocytes when deprived of 
serum (93). Long-term studies with serum-free cultures confirmed this as cells were incapable of 
surviving the impact regiment out to three weeks (data not shown).   For ECM expression levels, 
we observed increased sensitivity in astrocytes cultured in serum-containing media. One possible 
explanation stems from decreased quantities of focal adhesions when astrocytes are deprived of 
serum, thus decreasing sensitivity to mechanical stimulation (94). 
Overall, we present astrocytes modulate extracellular matrix in response to mechanical 
forces. We would be remised to not mention shortcomings in the experimental design. As stated 
previously, strain rate and angular accelerations are important parameters that effect the severity 
of injury. Unfortunately, with the present design of our device, we are incapable of controlling 
strain rate or applying angular accelerations. Further, we did not observe astrocyte behavior after 
mild TBI that complemented previous literature, instead likely applying an injury that initiated 
cell death and left surviving astrocytes in a severely damaged state. It would be of consequence 
to obtain a dose response curve to varying impacts by decreasing the release height of the shuttle. 
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We explored astrocytes response at acute time points; however, increasing the time in culture 
after injury may reveal alterations in ECM expression indicating the formation of a glial scar or 
simply resolving any alterations. A next generation TBI bioreactor is currently being created that 
will create a compression injury using a weight dropped onto astrocytes cultured in a hydrogel 
that mimics the brain’s mechanical properties (Appendix B Figure 1). The impact has been 
characterized for the bioreactor and peak pressures can be estimated from this characterization 
(Appendix B Figure 2). The affect of other cell types on astrocytes after injury is not explored 
here but could alter the response to injury. To complement this work, understanding the 
mechanism in which astrocytes sense and respond to mechanical stimulation is a logical next 
step. Increased permeability to calcium is a response to mechanical stimulation in astrocytes, 
thus a reasonable target to investigate is a calcium-specific mechanotransducer (95). Influx of 
calcium is reported to initiate astrogliosis in the central nervous system, therefore investigating 
mechanosensitive calcium channels may increase the understanding of the mechanisms that are 
responsible for altering cellular behavior after TBI and may reveal a therapeutic target for 
treating injury (96). Preliminary work has begun to investigate the potential role of calcium 
permeable channel transient receptor potential cation channel subfamily vanilloid member 4 
(TRPV4). As a preliminary step for future research, the influx of calcium has been observed by 
astrocytes in response to a TRPV4 agonist (Appendix C Figure 1).  
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VI. Tables and Figures 
 
Figure 1. Bioreactor capable of implementing mechanical stimuli mimicking a traumatic brain 
injury. The bioreactor is comprised of four main components: The guide rod (A) constricts the 
motion of the bioreactor to the vertical direction. The drop shuttle (B) comprises of two 
aluminum plates sandwiching a polypropylene layer. The bottom aluminum plate of the drop 
shuttle has six openings for custom made acrylic inserts that apply up to 30% biaxial strain to 
cultures (C). A steel plate mounted onto an interchangeable spring creates a spring dampened 
impact base prolonging the inertial forces felt by cell cultures (D). 
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Figure 2. Fabricated cell culture drums compatible with the mimetic traumatic brain injury 
bioreactor.  Cell culture drums are fabricated by creating a porous three-dimensional 
polyurethane foam and securing the foam to the base of a polypropylene cylinder (A). Biaxial 
strain can be applied to the cell culture by inserting an acrylic indenter into the elastic cell culture 
(B). The porous polyurethane foam exhibits elastic behavior at low strains and is shown at a 
relaxed and stretched state (C,D). Scale bars are representative as follows: Panel A – 1 cm, 
Panels C, D – 1 mm.  
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Table 1. Comparing bioreactor characteristics for three spring dampened bases 
Spring Spring Constant 
(lbs in-1) 
Impact Duration (ms) Peak Deceleration (G) Sensitivity  
(G cm-1) 
R2 
Stiff 959 1.6 ± 0.3  184.5 ± 26.6 0.726 0.947 
Medium 312 9.2 ± 1.2 158.2 ± 28.8 0.734 0.972 
Flexible 90 19.3 ± 0.5 59.1 ± 4.3 0.213 0.947 
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Figure 3.  Relative cell viability for astrocytes 24 hours following mimetic traumatic brain 
injury. A modified MTT Assay quantified the short term cell survival for astrocytes cultured 
with and without 10% fetal bovine serum following one or two TBI mimetic impacts. Impacted 
cultures were made relative to the single impact, serum containing media control (A). 
Withholding serum containing media and stimulating astrocytes with one or two TBI-like 
impacts decreased astrocyte survival compared to controls. MTT precipitates for controls (B) 
indicate strong astrocyte presence located within the seeding zone and little outgrowth into the 
surrounding scaffold. Lack of precipitation for impacted cultures (C) demonstrate areas with 
lowered cell density. * decrease from control (p<0.05), n=6, mean ± SEM.  
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Figure 4. Expression for common markers for reactive gliosis in astrocytes decreased 24 hours 
after mechanical stimulation. Vimentin expression (A) was reduced in single impact, serum 
containing media cultures, but remained unchanged in all other conditions. Surprisingly, GFAP 
expression (B), a hallmark of reactive gliosis, was suppressed in  all experimental conditions, 
though only significantly in single impact serum containing conditions and two impact serum 
withheld conditions. Additionally, S100B expression (C) was decreased across all experimental 
conditions. *significant difference from the control group (p<0.05), n=4-5, mean ± SEM. 
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Figure 5. Astrocyte gene expression for structural extracellular matrix proteins Collagen I (A), 
Neurocan (B), and Versican (C) six hours after mimetic TBI. Expression levels for each sample 
group are relative to the control of that group and normalized to the housekeeping gene GAPDH. 
Astrocytes cultured in serum containing media and given two mimetic TBIs separated by 24 
hours decreased expression of all ECM proteins tested.  Additionally, collagen I expression was 
decreased in astrocyte cultures receiving two impacts, no matter the media. Versican expression 
was decreased in impacted astrocyte cultured in serum containing media. * significant difference 
from control group (p<0.05), n=4, mean ± SEM. 
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Figure 6. Collection of astrocyte protein secretions for Matrix Metalloproteinase 2 (A), Tissue 
inhibitor of metalloproteinases 1 (B), and Transforming Growth Factor Beta 1 (C) 48 hours after 
mimetic TBI. Cell culture supernatants were collected 48 hours following the final impact for 
each treatment group. Protein concentrations were quantified using a colormetric sandwich 
ELISA kit. Concentrations were normalized to the viable cell counts reported previously. The 
ratio of the production of TIMP-1 to MMP-2 production (D) indicates an inhibition in the 
breakdown of ECM.   * significant difference from control group (p<0.05), n=4, mean ± SEM. 
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Figure 7.  Representative microscopic (100X) images of matrix protein accumulation and 
distribution after three weeks in culture for control and impacted scaffolds showing 
immunoreactivity for collagen type I (A&B), laminin (C&D), and CSPG (E&F). Quantitative 
analysis of extracellular matrix accumulation after three weeks for control and impacted 
scaffolds expressed as a percentage of the controls (G) showing that immunoreactivity against 
both collagen type I, and laminin CSPG was significantly reduced (* = t-test, p<0.05) in the 
impacted group when compared to static controls (mean ± SD, N =6/sample group). 
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Supplemental Figure 1. Inertial loading without stain on astrocytes resulted in middling 
expression levels for extracellular matrix proteins. Collagen I expression (A) and neurocan 
expression (B) were significantly reduced in cultures receiving two 150G impacts without biaxial 
strain compared to controls, though not as suppressed as cultures receiving two 150G impacts 
with biaxial strain. Versican expression (C) displayed a similar trend in two impact conditions 
though was not significant. The ratio of TIMP-1 to MMP-2 (D) found in the media 48 hours after 
impact without strain exhibited middling behavior between the control and impact with strain 
groups. Error bars are representative of SEM. Asterisks are indicative of significant difference 
from the control (p<0.05). 
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VII. Appendix A: Validating Astrocyte Purity through Image Processing 
The most common cell type used in studying astrocytes in the literature are primary cultures 
isolated from neonatal rat pup cortices.  The initial dissociation step results in a culture of mixed 
central nervous system cells containing neurons, oligodendrocytes, microglia, and astrocytes. To 
isolate astrocytes, a series of shaking steps are performed as astrocytes will adhere strongly to 
tissue culture plastic while other central nervous system cells adhere loosely. After shaking, 
cultures are passaged with some cells being plated onto coverslips for validation of the purity of 
the astrocyte culture. To use in downstream experiments, the user must first validate 90% of cells 
in the primary culture are astrocytes and are expressing GFAP, an established marker for 
astrocytes.  
Cells cultured on coverslips are incubated 1-2 days, fixed, and stained using a fluorescent marker 
for GFAP (indirect immunofluorescence staining) and cell nuclei (DAPI). The coverslips are 
imaged using fluorescent microscopy obtaining images of cell nuclei and GFAP at the same 
locations within the coverslip. Multiple images are obtained from each cover slip (4-5 images, 
use 5-6 cover slips). Images are loaded into a single folder and processed through a series of 
custom-built Matlab functions.  
The number of cells in the image is calculated using watershed segmentation of the DAPI image. 
First, the DAPI image is converted to grayscale and  enhanced by stretching the contrast across 
the dynamic range such that 50% of the pixels have a value of 0 and 1% of the pixels are 
saturated. Any nuclei touching the edges of the image are discounted. A Gaussian filter is 
applied to the image to eliminate local maxima within nuclei. Otsu’s method converts the 
grayscale image into a binary mask by setting a gray level threshold value that sends all pixels 
below the threshold to 0 and all pixels above the threshold to saturation. The threshold value is 
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determined by minimizing intragroup variation and maximizing intergroup variation. The binary 
mask is opened to eliminate small artifacts stemming from debris that are not corresponding to 
cells. The mask is applied to the enhanced DAPI image and the local maximum is found within 
each cell. The local maximum is isolated and dilated. Inverting the DAPI image with the dilated 
local maximum creates nuclei with deep ‘wells’ to improve the performance of watershed 
segmentation. Finally, watershed segmentation isolates individual nuclei and the built in Matlab 
function bwlabel outputs the number of cells in the image. In determining if the cell is GFAP 
positive, a mask is created around each cell nuclei from the DAPI image. The GFAP image is 
applied to the mask and the average intensity of the GFAP signal surrounding the nuclei is 
determined. If it is greater than the background signal, it is determined that the cell is expressing 
GFAP and can be counted as an astrocyte. In all experiments, cell cultures must contain a 
minimum of 90% GFAP positive cells. 
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VIII. Appendix B: Next Generation TBI Bioreactor 
 
One can argue that the elastic foam used to culture astrocytes in the traumatic brain injury 
bioreactor is not an accurate representation of the extracellular environment. To this end, 
modifications to the original device were performed to create an injury model better representing 
an insult that would lead to TBI (Figure A1). The modifications are summarized below: 
• Adding a second polypropylene plate to increase the space above the astrocyte culture 
• Replacing the polyurethane foam as a cell substrate by casting astrocytes in an alginate 
hydrogel or Matrigel 
• Removing the biaxial stretch injury indenter 
• Adding a Teflon weight that can carry additional stainless steel weights to control the 
mass compressing the gel 
• Exchanging the spring base with a foam base to increase impact duration and create a 
smooth impact profile 
The modifications improve the design of the bioreactor by first culturing cells in an environment 
better representing of the soft meshwork of extracellular proteins that make up the central 
nervous system. By using a weight to compress the gels, the cells are subject to the deceleration 
of the fall, pressure generated by the weight upon deceleration, and stretching as the gel deforms 
outwardly to fill the bottom of the cell culture drum in response to the pressure. The device has 
been characterized to determine peak decelerations over varying heights at 25cm increments 
(Figure A2). Adjusting the weight allows the user to control the pressure applied to the gel by 
Newton’s Second Law (Eq. 1) and the definition of pressure (Eq. 2). 
𝐹 = 𝑚𝑎  (Eq. 1) 
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𝑃 = &'  (2) 
𝑃 = ()'  (3) 
Peak pressures can be matched to physiological conditions experienced in the brain during an 
impact causing TBI. The flexibility of controlling the weight allows the user to investigate the 
effects of acceleration and pressure individually. Exchanging the spring base with a foam base 
created a smooth bell shaped impact profile similar to that previously reported in the literature 
(Figure A2). This is advantageous as the steel plate of the spring base expressed a rapid peak in 
deceleration that could be described as a jolt that could be inconsistent between drops.  
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Figure B1. Next Generation TBI Bioreactor. The bioreactor consists of an aluminum guide rod 
press fit into an aluminum base (A). The design of the shuttle includes two aluminum plates 
sandwiching two polypropylene plates with six holes cut out to house cell cultures (B). Cells are 
cultured in a polypropylene drum using PDMS as a base secured by a silicone O-ring (C). Cell 
cultures are injured using a Teflon weight placed on top of the culture that compresses the 
cultures upon impact. The weight can be adjusted by adding stainless steel rings onto the top of 
the weight. The base of the drop structure has been modified to have an egg crate base to create 
smooth loading and unloading curves. The shuttle can house six separate cultures (E). Astrocytes 
are cast into alginate gels (F,G) and are viable within the gels after 96 hours as determined by the 
fluorescent marker calcein (H). Scale bar is representative of 100 µm. 
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Figure B2. Characterization of Next Gen TBI Bioreactor. Representative curves of eight 
different drop heights display physiologically relevant deceleration profiles (A). The average 
peak deceleration at each drop height (n=10) established a quadratic relationship between drop 
height and peak deceleration (B). The full width half max, full width 20% max, and full width 
10% max describe the impact duration (C). The impulse is a measure of change of momentum 
and was calculated as the area under the acceleration curve multiplied by the maximum weight 
used in the bioreactor (0.383 g) (D). Jerk is the rate of change in acceleration and is calculated as 
the change in acceleration from the initial time point to the peak deceleration (E). 
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IX. Appendix C: TRPV4-Mediated Calcium Signaling 
Investigating pathways that astrocytes sense and respond to mechanical forces inducing an injury 
response is a future goal for our research group. One potential pathway to investigate is through 
the mechanically-sensitive calcium channel TRPV4(97). Chondrocytes respond to cyclical 
compression in vitro through the TRPV4 channel increasing extracellular matrix production and 
altering the mechanical and chemical properties of ECM(98). Knowing the modulations 
astrocytes perform in the CNS after insult, we hypothesize that the TRPV4 channel acts as a 
mechanotransducer in astrocytes presenting a pathway to sense injury and invoke a calcium 
response that triggers an injury cascade. As an initial step, we sought to discover if activating 
TRPV4 triggers an inflammatory response or altered extracellular matrix protein production in 
astrocytes. As an initial step, a dose response to a chemical agonist, GSK101 (Sigma Aldrich) 
was performed to determine concentrations required to invoke a cellular response. Intracellular 
calcium concentrations were measured using calcium sensitive Fura-2 dye. Briefly, astrocytes 
were seeded onto laminin-coated coverslips and incubated until cells reached confluency. Cells 
were rinsed with PBS and incubated in Fura-2 AM (Molecular Probes) for 30 minutes at room 
temperature. Cells were again rinsed in PBS and incubated in Tyrode’s Buffer (Sigma Aldrich) 
for 15 minutes at room temperature. Fresh Tyrode’s buffer was added prior to imaging. Cells 
(n=5) were imaged on an inverted microscope (Motic AE31) with emitted light captured using a 
photomultiplier (IonOptix) from excitation wavelengths of 340nm and 380nm sampling at 
500Hz. Cultures were imaged for 60 seconds to create a baseline. GSK101 was introduced at 
varying concentrations at the 60 second time point and calcium influx was recorded over the 
following 440 seconds. Traces were reported as the ratio of emission from 340nm to 380nm 
excitation wavelengths with increases in this ratio corresponding to an influx of calcium into the 
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cell. The baseline ratio subtracted from the peak 340nm/380nm ratio and normalized to the 
baseline provided a unitless measure to compare the calcium response to the introduction of the 
agonist. Overall, a trend of increased intracellular calcium concentrations is observed in response 
to higher concentrations of GSK101 (Figure B1). However, a one-way ANOVA did not show 
significant differences between any treatment groups. Large variances within treatment groups 
likely prevented a significant result to be observed.  
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Figure C1. Calcium Influx in Astrocytes in Response to TRPV-4 Agonist.  Representative 
curves of the ratio of emission when excited at 340nm and 380nmfor astrocytes treated with a 
TRPV4 agonist GSK101 at 0nM (A), 10nM (B), 100nM (C), 500nM (D), and 1000nM (E). 
Increases to the 340nm/380nm corresponds to intracellular increases in calcium stemming from 
the opening of the calcium channel TRPV4. The average difference between the peak 
340nm/380nm ratio and baseline ratio was normalized to the baseline ratio for each culture 
(n=5/concentration) (F). Error bars are representative of SEM. 
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X. Appendix D: IACUC Protocol Approval #15013 
 
